testosterone propionate has been researched along with equol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Haldy, ME; Handa, RJ; Lephart, ED; Lund, TD; Munson, DJ; Setchell, KD | 1 |
2 other study(ies) available for testosterone propionate and equol
| Article | Year |
|---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback.
Topics: Androgen Antagonists; Animals; Dihydrotestosterone; Equol; Feedback, Physiological; Growth Inhibitors; Hormones; Isoflavones; Luteinizing Hormone; Male; Orchiectomy; Prostate; Rats; Rats, Sprague-Dawley; Testosterone Propionate | 2004 |